Carbapenem-Resistant Enterobacteriaceae Infection Clinical Trials
2 recruiting trials for Carbapenem-Resistant Enterobacteriaceae Infection. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT04014413
Safety and Efficacy of Fecal Microbiota Transplantation
The gut microbiota is critical to health and functions with a level of complexity comparable to that of an organ system. Dysbiosis, or alterations of this gut microbiota ecology,...
Sponsor: Chinese University of Hong KongEnrolling: 4501 location
RECRUITINGNCT06051513
Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae...
Colistin can be used to treat the infection caused by carbapenem-resistant enterobacteriaceae(CRE). In China, patients diagnosed with Hospital-acquired-pneumonia (HAP)or...
Sponsor: Southeast University, ChinaEnrolling: 40415 locations